Skip Navigation



Human Molecular Genetics Advance Access published online on September 9, 2005

Human Molecular Genetics, doi:10.1093/hmg/ddi337
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
14/20/3047    most recent
ddi337v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Xiang, P.
Right arrow Articles by Li, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiang, P.
Right arrow Articles by Li, Q.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved
Received April 30, 2005
Revised August 3, 2005
Accepted September 6, 2005

Article

Juxtaposition of the HPFH2 enhancer is not sufficient to reactivate the {gamma}-globin gene in adult erythropoiesis

Ping Xiang 1, Hemei Han 1, Grainne Barkess 1, Ivan Olave 1, Xiangdong Fang 1, Wenxuan Yin 1, George Stamatoyannopoulos 1, and Qiliang Li 2*

1 Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA, 98195
2 Division of Medical Genetics, Department of Medicine, University of Washington, Box 357720, Seattle, WA, 98195

* To whom correspondence should be addressed.
Qiliang Li, E-mail: li111640{at}u.washington.edu


   Abstract

Previous studies have suggested that juxtaposition of a downstream enhancer to the fetal {gamma}-globin gene results in reactivation of the {gamma} gene in adult erythrocytes of individuals with hereditary persistence of fetal hemoglobin (HPFH). To test the hypothesis in a much stricter basis, we produced {beta} locus YAC transgenic mice carrying an exact {beta} locus replicate of a deletional HPFH mutation, HPFH 2. While the {gamma}-globin gene was expressed in the HPFH 2/ {beta} locus YAC (HPFH 2/YAC) transgenic mice in the early stage of development, it was completely silenced in the adult mice. The failure of {gamma} gene reactivation by the juxtaposed HPFH 2 enhancer contradicts the results of previous studies. We speculate that the discrepant results reflect differences in the distance between the LCR and the {gamma}-globin gene characteristic of the plasmid, cosmid, or YAC constructs used for production of transgenic mice. The difference in the phenotype of the HPFH 2/YAC transgenic mice and the humans with HPFH 2 mutation suggests that in addition to juxtaposition of HPFH enhancers, the upstream region that is absent in the {beta}-YAC construct might be involved in {gamma} gene reactivation in HPFH individuals. The DNase I hypersensitive sites of the LCR were well formed and the chromatin histones were acetylated. A moderate level of pol II binding was detected in the LCR despite the fact that no transcription occurred in the globin genes of the adult HPFH 2/YAC transgenic mice. The results suggest that formation of the LCR chromatin structure in erythroid cells is independent of globin gene transcription in the locus.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.